Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses-Reference-Cited by-全球学者库

Development of Neutralizing Nanobodies to the Hemagglutinin Stem Domain of Influenza A Viruses

Published:2021-12-15 Issue:4 Volume:13 Page:33-41
ISSN:2075-8243
Container-title:Acta Naturae
language:
Short-container-title:Acta Naturae

Author:

Voronina Daria V.^ORCID,Shcheblyakov Dmitry V.,Esmagambetov Ilias B.,Derkaev Artem A.,Popova Olga,Shcherbinin Dmitry N.

Abstract

The influenza virus infection claims ~650,000 lives annually. Taking into account the evolving resistance of the pathogen to antiviral drugs and the waning effectiveness of vaccination among certain populations, new approaches to the treatment of influenza are needed. The current study is aimed at obtaining single-domain antibodies (Nanobodies) to the highly conserved stem domain of influenza A virus hemagglutinin by phage display. Two high-affinity neutralizing clones of Nanobodies with a particular specificity were selected; they ensured 100% neutralization of the H1N1 and H5N2 influenza viruses in vivo. The obtained data demonstrate that it is possible to develop highly effective VHH-based drugs for the treatment of influenza.

Publisher

Acta Naturae Ltd

Link

https://actanaturae.ru/2075-8251/article/viewFile/11495/pdf

Reference37 articles.

1. Gamblin S.J., Skehel J.J. // J. Biol. Chem. 2010. V. 285. № 37. P. 28403–28409.

2. Krammer F., Palese P. // Nat. Rev. Drug Discov. 2015. V. 14. № 3. P. 167–182.

3. Ekiert D.C., Friesen R.H.E., Bhabha G., Kwaks T., Jongeneelen M., Yu W., Ophorst C., Cox F., Korse H.J., Brandenburg B., et al. // Science. 2011. V. 333. № 6044. P. 843–850.

4. Throsby M., van den Brink E., Jongeneelen M., Poon L.L.M., Alard P., Cornelissen L., Bakker A., Cox F., van Deventer E., Guan Y., Cinatl J., et al. // PLoS One. 2008. V. 3. № 12. P. e3942.

5. Sui J., Hwang W.C., Perez S., Wei G., Aird D., Chen L.M., Santelli E., Stec B., Cadwell G., Ali M., et al. // Nat. Struct. Mol. Biol. 2009. V. 16. № 3. P. 265–273.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promises and challenges of single-domain antibodies to control influenza;Antiviral Research;2024-02

2. Feeding secondary fermentations with mammalian and fungal culture waste streams increases productivity and resource efficiency;2023-10-17

3. Production and characterisation of a SARS-CoV-2 S-protein RBD homodimer with increased avidity for specific antibodies;Biological Products. Prevention, Diagnosis, Treatment;2023-01-02

4. Cross-Reactive Fc-Fused Single-Domain Antibodies to Hemagglutinin Stem Region Protect Mice from Group 1 Influenza a Virus Infection;Viruses;2022-11-10

5. Cross-reactive single-domain antibodies to hemagglutinin stem region protect mice from group 1 influenza A virus infection;2022-09-30